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Abstract Here we show that El ,  an ankyrin-related, potentially 
protective, neuronal protein of the human filarial nematode 
Onchocerca volvulus contains a death domain (DD), most similar 
to that of human MUrtl/FADD (39% identity). In addition, 
sequence comparison of E1 to its homologue from Litomosoides 
sigmodontis and to Caenorhabditis elegans ankyrin defines two 
further putative functional domains. One represents the end of 
the spectrin-binding domain of ankyrins, the other an unique 
domain, most highly conserved between these nematodes, 
containing a calpain sequence motif. Thus, E1 may be involved 
in apoptosis, raising the possibility that protection against this 
parasitic helminth may be induced by apoptotic processes. 
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1. Introduction 
Apoptosis induced by Fas/Apol and TNF-R is dependent 
on a so-called death domain (DD), a sequence motif of ap- 
prox. 65 amino acids present in the cytoplasmic portion of 
these molecules, which is necessary and sufficient for the 
transduction of the cell death signal [1,2]. DDs have recently 
been identified in several molecules, predominantly in those 
directly associated with cell death, but also in a few others 
where involvement in cell death has not yet directly been 
addressed [3-5]. The latter include human ankyrins, their 
best known function being attachment of membrane proteins 
to the cytoskeleton [6], as well as a transcript of the ankyrin 
gene of the free-living nematode Caenorhabditis elegans, which 
is essential in axon guidance [7]. 
E1 is an ankyrin-related protein of the filarial nematode 
Onchocerca volvulus [8], the causative agent of human oncho- 
cerciasis. E1 has been identified by immunoscreening of an O. 
volvulus cDNA library with sera from persons putatively im- 
mune to onchocerciasis. It has homology to human brain 
ankyrin [9] as well as to an C. elegans ankyrin [7]. In O. 
volvulus E1 was primarily localized in the nervous ystem of 
the worm [8], including the sensory axons in the cephalic 
space of this nematode [10], and represents the first cloned 
neuronal protein of a parasitic nematode. To enable testing 
of the protective potential of E1 in animal models we have 
cloned an E1 homologue from the rodent filarial parasite 
Litomosoides igmodontis. Comparison of this sequence to 
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44 gene, ankyrin-related gene of Caenorhabditis elegans 
that of O. volvulus as well as the analysis of the genomic 
organization of E1 in O. volvulus led to the recognition of 
three putative functional domains, including a DD, raising 
the possibility that E1 is involved in apoptosis. 
2. Material and methods 
2.1. Parasites 
Adult O. volvulus worms were obtained from surgically removed 
nodules and processed as previously described [8]. L. sigmodontis 
adult worms were kindly provided by Dr. A. H6rauf at the Bernhard 
Nocht Institute in Hamburg, Germany. 
2.2. RT-PCR, PCR and DNA sequencing 
After isolation of total L. sigmodontis RNA, using an RNA extrac- 
tion kit (TRIzol Reagent, Gibco, BRL), cDNA was obtained by re- 
verse transcription using oligo-dT primers. PCR of the cDNA, carried 
out using primers derived from nucleotide positions 468-489 (for- 
ward) and 1836-1856 (reverse) of the O. volvulus E1 cDNA sequence 
[8], was followed by cloning of the PCR products into the pCR II 
vector (TA Cloning kit, Invitrogen, San Diego, CA, USA). To deter- 
mine the genomic structure of the O. volvulus El cDNA, genomie 
DNA was isolated from O. volvulus as previously described [8] and 
PCR amplification was carried out using a primer pair spanning the 
entire nucleotide sequence ofthe E1 cDNA. The nucleotide sequences 
were determined in both orientations using [cx-35S]dATP and a se- 
quenase kit (US Biochemical Corp., Cleveland, OH, USA). Searches 
of the SwissProt protein database were performed using the FASTA 
program. 
3. Results 
3.1. cDNA cloning and sequence comparisons 
Cloning of the L. sigmodontis cDNA corresponding to the 
O. volvulus E1 cDNA and comparison between the respective 
predicted amino acid sequences indicates that the L. sigmo- 
dontis sequence is overall highly similar (72% identity) (Fig. 
1). However, the similarities are clustered in three major re- 
gions, whereby flanking regions are less similar (Fig. 1). Align- 
ment of both sequences with the C. elegans ankyrin A049, 
product of the unc-44 gene [7], confirms that three regions 
are highly conserved between these nematodes and delineates 
these domains as shown in Fig. 1. Thus, domain I encom- 
passes 101 amino acids, domain II 61 amino acids and do- 
main III 57 amino acids. Amino acid identities between O. 
volvulus and L. sigmodontis are 85% for domain I, 90% for 
domain II and 93% for domain III, while the intervening 
sequences are less conserved (50% and 64% identical, respec- 
tively). The comparison between the O. volvulus and C. ele- 
gans amino acid sequences indicates identities of 75% for do- 
main I, 54% for domain II and 86% for domain III, the 
intervening sequences being completely dissimilar (Fig. 1). 
Amino acid sequence comparison of the domains with 
known protein sequences indicates that domain I is highly 
similar to the C-terminal region of the spectrin-binding do- 
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Fig. 1. Alignment of the amino acid sequences of O. volvulus El, its homologue from L. sigmodontis and the C. elegans A049 ankyrin [7]. The 
three conserved omains are boxed. Identical amino acids in the L. sigmodontis and C. elegans sequences are represented by dashes, and gaps, 
introduced to maximize alignment, are indicated by a blank space. 
main of human ankyrins [9,11-13] (43% identity to human 
brain ankyrin). Domain II contains a conserved motif known 
as the death domain (DD) [1,2]. Alignment of the E1 protein 
sequence with the DD of several proteins is shown in Fig. 2A. 
Identities between E1 and these human proteins are 30% for 
ankyrin 1 [11], 22% for Fas/APO1 [14], 39% for Mort l /FADD 
[15,16], 24% for p55 TNF-R [17,18] and 29% for NGF-R [19]. 
The identity to Mort l /FADD [15,16] is also the highest 
among two members of the DD protein family [3], whereby 
the O. volvulus ankyrin sequence is more identical to the DD 
of the human Mort l /FADD than to the DD of human an- 
kyrins. The valine residue at position 239 of Fas/Apol was 
shown to represent a functional residue [1], since point muta- 
tions at this position abolish the ability of cell death signal 
transduction. This valine residue is conserved in the nema- 
tode, but not in the human ankyrins (Fig. 1) [9,11-13]. 
Domain III shows the highest degree of conservation be- 
tween the three nematode species (Fig. 1). Similarity searches 
of domain III with protein sequences in the data bank re- 
vealed no significant identities over the entire sequence to 
other proteins. However, a short sequence motif from amino 
acid 39-56 of this domain which is 65% identical to human 
and rat calpain (large subunit) [20,21] is found (Fig. 2B). 
3.2. Genomic sequence analysis 
Analysis of the genomic DNA fragment encoding the O. 
volvulus E1 cDNA indicates that the cDNA is encoded on 
9 exons divided by 8 introns (Fig. 2C). In contrast, the corre- 
sponding C. elegans genomic region contains 3 exons inter- 
rupted by 2 introns [7] (Fig. 2C). In O. volvulus each of the 
three domains is encoded on 2 exons (Fig. 2C), whereby in C. 
elegans domain I and II are both encoded on the same large 
exon [7] (Fig. 2C). In O. volvulus domain III is encoded on 
exons 6 and 7, whereby the boundary of exon 6 precisely 
matches the boundary of the start of domain III in the pro- 
tein. The coding sequence for domain III continues on exon 7 
which encodes only the following 18 amino acids. In C. ele- 
gans exon B corresponds exactly to domain III [7] (Fig. 2C). 
4. D iscuss ion  
The analysis presented here defines three domains which are 
highly conserved in nematode ankyrins. The first domain is 
also highly conserved in ankyrins from vertebrates [9,11-13], 
where it is found at the C-terminal end of the so-called spec- 
trin-binding domain [22]. However, this conserved region is 
not directly involved in binding to spectrin, and its exact 
function remains to be determined [23]. 
Similarly, the third domain recognized here has not yet 
been functionally characterized. The high degree of conserva- 
tion as well as its genomic organization in both O. volvulus 
and C. elegans trongly suggests that it is functionally impor- 
tant in nematodes. In spite of its almost complete conserva- 
tion in nematodes we could not detect a corresponding do- 
main in the vertebrate ankyrins known to date. The fact that 
in nematodes it is precisely encoded on separate xons and is 
not part of the exons encoding other portions of the ankyrin 
molecule, such as the spectrin-binding domain, could indicate 
that in vertebrates this domain is encoded on another, as yet 
unidentified, gene. It has been suggested that the nematode 
ankyrin gene is ancestral to the multiple ankyrin genes of 
vertebrates [7]. Interestingly, splicing events occur in the par- 
ticular region of mammalian ankyrins where domain III is 
localized in the nematode ankyrins [9,11-13]. These events 
result in the presence or absence of different inserts which 
are not related to the nematode domain III, but which appear 
related to the function and the tissue specificty of the respec- 
tive ankyrin [11-13]. If indeed, domain III proves to be ne- 
matode-specific, together with its suggested functional impor- 
tance it could represent a particularly attractive target for 
immune-mediated protection studies. 
A sequence comparison of domain III to proteins in the 
data bank revealed no significant identities over the entire 
domain, however one region of this domain is similar to a 
motif found in the protease calpain, located in the proteolytic 
site of the enzyme [20,21]. Calpain is a protease with defined 
substrate specificities which include spectrin, fodrin [24] and 
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Fig. 2. (A) Alignment of the DDs of O. volvulus E1 [8], human ankyrinl [11], Fas/Apol [14], Mortl/FADD [15,16], p55 TNF-R [17,18] and 
NGF-R [19]. Identical amino acids are boxed and darkly shaded, amino acids considered conserved are boxed and lightly shaded; gaps intro- 
duced to maximize alignment are represented bydashes. The position of the valine residue, essential for apoptotic signalling, is indicated by an 
asterisk. (B) Alignment of the regions of domain III of O. volvulus, L. sigmodontis and C. elegans howing similarity to human and rat calpain 
[20,21] using the program FASTA. Matches between identical amino acids are shaded in dark, conservative amino acid matches are lightly 
shaded. (C) Schematic representation f the O. volvulus genomic region encoding E1 and comparison with the corresponding genomic fragment 
of the C. elegans unc-44 ankyrin gene [7]. Exons are boxed and numbered 1-9 for the O. volvulus equence and labeled A~C for the C. elegans 
sequence. The locations of domain I-III and of the intervening sequences on the exons are indicated by white or shaded and black boxes, re- 
spectively. 
ankyrin [25], its activity being associated with cell death [26], 
particularly during neurodegeneration [27]. Future studies can 
address whether this domain has proteolytic activity or inter- 
acts with other proteins. As this domain is highly conserved in 
C. elegans, mutagenesis studies could be used to elucidate its 
function. 
In contrast to domains I and III, the second domain found 
in the O. volvulus and L. sigmodontis ankyrins, corresponds to
a functionally characterized protein domain, the so-called 
DD. The DD is essential for the transduction of the cell death 
signal in apoptotic molecules [1,2] and is also conserved in 
human and C. elegans ankyrins [3-5]. As shown here, the 
O. volvulus E1 protein as well as its L. sigmodontis homologue 
are members of this DD protein family. A characteristic fea- 
ture of DDs from different proteins is their ability to self- 
associate [1,2]. The DD in Mortl/FADD, to which the DD 
in E1 is most similar, has been shown to associate also with 
the DDs of other signalling receptors, particularly with the 
DD of Fas/APO1, suggesting that it may be a mediator of 
functional cross-talk between different apoptosis receptors 
early in their signaling cascades [28]. Further studies will ad- 
dress whether the DD in E1 is functional in apoptosis and 
whether it interacts with DDs of other proteins. 
E1 as an immunogen for putatively immune individuals 
together with its localization in the nervous system of the 
worm [8], including the neuronal structures which are exposed 
to the environment via the amphids [10], have implicated that 
antibodies against neuronal structures may be involved in 
protection against parasitic helminths [8]. The present results 
address the molecular mechanisms involved in this protective 
process, raising the question of whether apoptotic mechanisms 
during neuronal development are involved, and provide an 
experimental basis for future studies in this direction. Indeed, 
apoptosis plays a central role in the development of the eu- 
karyotic nervous ystem [29] and the function of the nervous 
system appears essential for the development and survival of 
parasitic nematodes in their hosts [30]. In this regard inter- 
ference with the neuronal apoptotic pathway may represent 
an effective strategy to control parasitic helminths, which has 
not yet been pursued. Induction of apoptosis has been dis- 
cussed in therapeutic strategies for cancer, autoimmune dis- 
eases and viral infections. The present results uggest that this 
24 K.D. Erttmann et al./FEBS Letters 390 (1996) 21-24 
may also be evaluated in control strategies against parasitic 
helminths. 
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